Cambria Investment Management, L.P. United Therapeutics Corp Transaction History
Cambria Investment Management, L.P.
- $1.36 Billion
- Q1 2025
A detailed history of Cambria Investment Management, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cambria Investment Management, L.P. holds 2,236 shares of UTHR stock, worth $665,344. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,236
Previous 1,074
108.19%
Holding current value
$665,344
Previous $378,000
82.28%
% of portfolio
0.05%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding UTHR
# of Institutions
734Shares Held
43.1MCall Options Held
125KPut Options Held
124K-
Black Rock Inc. New York, NY5.47MShares$1.63 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.33 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$796 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$664 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$627 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...